Sung-Won Jang
Overview
Explore the profile of Sung-Won Jang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang Y, Jang S
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004684
Whether remote monitoring reduces mortality in patients with heart failure remains controversial, and research on remote monitoring in South Korea is generally lacking. Therefore, we aim to evaluate the safety...
2.
Jang J, Park S, Kim S, Kim S, Oh Y, Sa Y, et al.
Eur J Prev Cardiol
. 2023 Oct;
31(3):320-329.
PMID: 37798123
Aims: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to improve cardiovascular outcomes and reduce the incidence of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM). We investigated...
3.
Kwon O, Myong J, Lee Y, Choi Y, Yi J, Seo S, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e027824.
PMID: 37421263
Background Whether the early use of sodium-glucose cotransporter-2 (SGLT2) inhibitors have cardioprotective effects following acute myocardial infarction is unknown. Thus, we aimed to evaluate the association between the early initiation...
4.
Choi Y, Kim S, Kim H, Park J, Ha Y, Hwang Y, et al.
J Cardiovasc Electrophysiol
. 2022 Aug;
33(10):2164-2171.
PMID: 35924472
Introduction: Novel ablation catheters equipped with mini-electrodes (ME) offer high resolution mapping for target tissue. This study aimed to evaluate the mapping performance and efficacy of ME catheters in radiofrequency...
5.
Kim J, Kim K, Tae Y, Chang M, Park S, Park K, et al.
Front Cardiovasc Med
. 2022 Jul;
9:906780.
PMID: 35872911
Background: Subclinical atrial fibrillation (AF) is one of the pathogeneses of embolic stroke. Detection of occult AF and providing proper anticoagulant treatment is an important way to prevent stroke recurrence....
6.
Kim J, Park S, Lee S, Seo G, Jang S
Europace
. 2022 Jun;
24(12):1967-1972.
PMID: 35696285
Aims: The incidence of infective endocarditis related to cardiac implantable electronic devices (CIEDs) has gradually increased. The risk associated with dental procedures in patients with CIED implantation and the need...
7.
Lee M, Han S, Bang O, On Y, Jang S, Han S, et al.
Adv Ther
. 2022 May;
39(7):3112-3130.
PMID: 35524839
Introduction: Treatment persistence for anticoagulant therapy is important in preventing thromboembolism in nonvalvular atrial fibrillation (NVAF) patients. Understanding drug utilization pattern and treatment changes in oral anticoagulant (OAC) users may...
8.
Bang O, Kim S, On Y, Lee M, Jang S, Han S, et al.
Front Neurol
. 2022 Mar;
13:761603.
PMID: 35309578
Objective: Non-vitamin K antagonist oral anticoagulants (NOACs) are proven alternatives to warfarin for preventing stroke in patients with non-valvular atrial fibrillation. We aimed to examine the treatment patterns and patient...
9.
Han S, Han S, Suh H, Bang O, On Y, Lee M, et al.
J Arrhythm
. 2021 Oct;
37(5):1240-1249.
PMID: 34621422
Background: To compare the risk of stroke/systemic embolism (S/SE) and major bleeding (MB) between non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF), this retrospective study was...
10.